Finance

Senarai
Sebab BT3 meningkat 2.14%?
Terokai Dengan Lebih Terperinci
BT3:FRA
Lineage Cell Therapeutics Inc
€0.76
+2.14%
(+0.016) 1H
20 Nov, 10:00:00 PTG GMT+1  ·   EUR
Semua simbol
SimbolHargaPerubahan% Perubahan
Menjana cerapan popular untuk BT3...
Buka
€0.76
Tinggi
€0.76
Rendah
€0.76
Permodalan Pasaran
195.26J
Purata volum
100.00
Volum
0.00
tgi 52 mgu
€1.68
rdh 52 mgu
€0.72
Bilangan pekerja
75
Buka
€0.76
Tinggi
€0.76
Rendah
€0.76
Permodalan Pasaran
195.26J
Purata volum
100.00
Volum
0.00
tgi 52 mgu
€1.68
rdh 52 mgu
€0.72
Bilangan pekerja
75
Cerita berita
Daripada sumber web dan rakan kongsi berita
Profil
Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. With this platform, Lineage develops and manufactures specialized, terminally differentiated human cells from its pluripotent and progenitor cell starting materials. These differentiated cells are developed to either replace or support cells that are dysfunctional or absent due to degenerative disease or traumatic injury or administered as a means of helping the body mount an effective immune response to cancer. Wikipedia
Perihal Lineage Cell Therapeutics Inc
CEO-
Pekerja75
Diasaskan1990
Ibu pejabat-
SektorHealth Care
Industri-
Laporan sebelumnyaSemua nilai dalam USD
Loading Previous Earnings...
Hasil
Pendapatan bersih
Semua nilai dalam USD
Dis 2025
Mac 2026
Jun 2026
Sep 2026
Hasil
6.61J
1.72J
1.07J
1.43J
Kos barangan yang dijual
8.30J
4.23J
4.77J
3.82J
Kos hasil
8.30J
4.23J
4.77J
3.82J
Perbelanjaan penyelidikan dan pembangunan
-
-
-
-
Jumlah perbelanjaan penyelidikan dan pembangunan
-
-
-
-
Perbelanjaan jualan, am dan pentadbiran
4.85J
5.08J
5.22J
4.92J
Belanja kendalian
4.85J
5.08J
5.22J
4.92J
Jumlah belanja kendalian
13.16J
9.32J
9.99J
8.75J
Pendapatan kendalian
-6.55J
-7.59J
-8.92J
-7.31J
Pendapatan bukan kendalian lain
1.29J
2.32J
9.42J
11.94J
EBT termasuk item luar biasa
-4.39J
-4.79J
1.54J
4.71J
EBT tidak termasuk item luar biasa
-4.38J
-4.81J
1.54J
4.72J
Belanja cukai pendapatan
-5.28J
-
-
484.00K
Kadar cukai berkesan
120.33%
-
-
10.27%
Belanja kendalian lain
-
-
-
-
Pendapatan bersih
851.00K
-4.81J
1.48J
4.23J
Margin untung bersih
12.88%
-278.96%
138.63%
295.12%
Perolehan bagi setiap syer
-
-0.02
0.01
-0.03
Pendapatan faedah dan pelaburan
393.00K
405.00K
378.00K
376.00K
Belanja faedah
-
-
-
-
Belanja faedah bersih
393.00K
405.00K
378.00K
376.00K
Caj susut nilai dan pelunasan
-
-
-
-
EBITDA
-6.36J
-7.40J
-8.74J
-7.11J
Keuntungan atau kerugian daripada jualan aset
-
12.00K
19.00K
-
Acara akan datang
Kandungan AI boleh mengandungi kesilapan. Ketahui lebih lanjut
BantuanHantar maklum balasPrivasiSyaratPenafian
Apl Google